Mavik and Urinary incontinence - a phase IV clinical study of FDA data
Summary:
No or too few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or too few reports are found.
What is Mavik?
Mavik has active ingredients of trandolapril. It is used in high blood pressure. Currently, eHealthMe is studying from 3,096 Mavik users.
What is Urinary Incontinence?
Urinary incontinence (inability to control the flow of urine and involuntary urination) is found to be associated with 3,079 drugs and 2,431 conditions by eHealthMe. Currently, we are studying 47,959 people who have Urinary incontinence.
Do you take Mavik and have Urinary incontinence?
Check whether Urinary incontinence is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Mavik side effects by duration, gender and age:
- Mavik side effects (3,096 reports)
Urinary incontinence treatments and more:
- Urinary incontinence (47,959 reports)
All the drugs that are associated with Urinary incontinence:
All the conditions that are associated with Urinary incontinence:
How the study uses the data?
The study uses data from the FDA. It is based on trandolapril (the active ingredients of Mavik) and Mavik (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ciprofloxacin and Silymarin drug interaction - 26 seconds ago
- Cefazolin and Tacrolimus drug interaction - a minute ago
- Fluoxetine and Vasculitis - a minute ago
- Coumadin and Singulair drug interaction - a minute ago
- Pepcid and Furuncle - 2 minutes ago
- Atenolol and Dry Skin - 2 minutes ago
- Ceclor and Miralax drug interaction - 2 minutes ago
- Flonase and Xiidra drug interaction - 3 minutes ago
- Zyprexa and Megace Es drug interaction - 3 minutes ago
- Adapalene and Skin Hyperpigmentation - 3 minutes ago